Continuing Education Activity

Acute bronchitis is the inflammation of the lining of the bronchi. It is a common presentation in emergency departments, urgent care centers, and primary care offices. In the United States, acute bronchitis is among the top ten most common illnesses among outpatients; about five percent of adults have an episode of acute bronchitis each year. This activity reviews the evaluation and management of patients with acute bronchitis and highlights the role of the interprofessional team in caring for patients with this condition.

Objectives:

• Describe the presentation of a patient with acute bronchitis.
• Explain how to distinguish acute bronchitis from pneumonia.
• Outline the management and treatment options for acute bronchitis.
• Summarize the importance of the interprofessional team in caring for and counseling patients with acute bronchitis.

Introduction

Acute bronchitis is an inflammation of the large airways of the lung. It is a common clinical presentation to emergency departments, urgent care centers, and primary care offices. About 5% of adults have an episode of acute bronchitis each year. An estimated 90% of these seek medical advice for the same. In the United States, acute bronchitis is among the top ten most common illnesses among outpatients.[1][2][3]

Etiology

Acute bronchitis is caused by infection of the large airways commonly due to viruses and is usually self-limiting. Bacterial infection is uncommon. Approximately 95% of acute bronchitis in healthy adults is secondary to viruses. It can sometimes be caused by allergens, irritants, and bacteria. Irritants include smoke inhalation, polluted air inhalation, dust, among others.[4]

Epidemiology

Acute bronchitis is one of the common presentations in any healthcare setting. It is estimated that every year, 5% of the general population reports an episode of acute bronchitis, accounting for more than 10 million office visits yearly.[5] Like most of the viral diseases of the respiratory tract, acute bronchitis is commonly seen during the flu season. In the United States, flu season is common during autumn and winter. It can follow any viral upper respiratory infection (URI). The common pathogens are respiratory syncytial virus, influenza virus A and B, parainfluenza, rhinovirus, and other similar viruses.

Factors like a history of smoking, living in a polluted place, crowding, and a history of asthma, are all risk factors for acute bronchitis. In some people, acute bronchitis can be triggered by particular allergens like pollens, perfume, and vapors.

When the infection is bacterial, the isolated pathogens are usually the same as those responsible for community-acquired pneumonia, for example, Streptococcus pneumonia and Staphylococcus aureus.[6][7]

Pathophysiology

Acute bronchitis is the result of acute inflammation of the bronchi secondary to various triggers, most commonly viral infection, allergens, pollutants, etc. Inflammation of the bronchial wall leads to mucosal thickening, epithelial-cell desquamation, and denudation of the basement membrane. At times, a viral upper respiratory infection can progress to infection of the lower respiratory tract resulting in acute bronchitis.[8]

History and Physical

Patients with acute bronchitis present with a productive cough, malaise, difficulty breathing, and wheezing. Usually, their cough is the predominant complaint and the sputum is clear or yellowish, although sometimes it can be purulent. Purulent sputum does not correlate with bacterial infection or antibiotic use.[9] Cough after acute bronchitis typically persists for 10 to 20 days but occasionally may last for 4 or more weeks. The median duration of cough after acute bronchitis is 18 days.[10] Paroxysms of cough accompanied by inspiratory whoop or post-tussive emesis should raise concerns for pertussis. A prodrome of upper respiratory infection (URI) symptoms like runny nose, sore throat, fever, and malaise are common. A low-grade fever may be present as well. High-grade fevers in the setting of acute bronchitis are unusual and further diagnostic workup is required.

On physical exam, lung auscultation may be significant for wheezing; pneumonia should be suspected when rales, rhonchi, or egophony are appreciated. Tachycardia can be present reflecting fever as well as dehydration secondary to the viral illness. The rest of the systems are typically within normal limits.

Evaluation

Acute bronchitis is a clinical diagnosis based on history, past medical history, lung exam, and other physical findings. Oxygen saturation plays an important role in judging the severity of the disease along with the pulse rate, temperature, and respiratory rate. No further workup is needed if vital signs are normal and there are no exam findings suggestive of pneumonia. An exception to this rule is elderly patients >75 years old. Also, further workup is needed when pneumonia is suspected, the clinical diagnosis is in question, or in cases of high suspicion for influenza or pertussis. 

Chest x-ray (CXR) findings are not specific and are typically normal. Occasionally, the chest x-ray demonstrates increased interstitial markings consistent with the thickening of bronchial walls. A chest x-ray differentiates pneumonia from acute bronchitis when infiltrates are seen. Evidence-based guidelines from the American College of Chest Physicians (ACCP) recommend obtaining a CXR only when heart rate > 100/min, respiratory rate >24 breaths/min, oral body temperature > 38 degrees C, and chest examination findings of egophony or fremitus.[5]

A complete blood count and chemistry may be ordered as a workup for fever. The white blood count might be mildly elevated in some cases of acute bronchitis. Blood chemistry can reflect dehydration changes.

Routine use of rapid microbiological testing is not cost-effective and would not change management except during influenza season and in cases with high suspicion of pertussis or other bacterial infection. Gram stain and bacterial sputum cultures are specifically discouraged as bacteria are rarely the causative agent. 

Spirometry, when performed, demonstrates transient bronchial hyperresponsiveness in 40% of patients with acute bronchitis. Reversibility of FEV1 >15% is reported in 17% of patients.[5] Airflow obstruction and bronchial hyperresponsiveness typically resolve in 6 weeks.

Treatment / Management

Acute bronchitis is self-limiting and treatment is typically symptomatic and supportive therapy. For cough relief, nonpharmacological and pharmacological therapy should be offered. Nonpharmacological therapy includes hot tea, honey, ginger, throat lozenges, etc. No clinical trials evaluated the efficacy of these interventions. Antitussive agents like dextromethorphan and codeine are frequently used in clinical practice to suppress cough based on their effectiveness in chronic bronchitis and studies on cough in the common cold. No randomized trials exist to evaluate their effectiveness in acute bronchitis. Codeine should be avoided due to its addictive potential. Data on the use of a mucolytic agent is conflicting. 

Beta-agonists are routinely used in acute bronchitis patients with wheezing. Small randomized control trials on beta-agonists for cough in acute bronchitis had mixed results. A Cochrane review of five trials demonstrated no significant benefit of beta-agonists on daily cough except for a small benefit in a subgroup of patients with wheezing and airflow obstruction at baseline.[11] A more recent Cochrane review demonstrated similar results.[12] 

Analgesic and antipyretic agents may be used to treat associated malaise, myalgia, and fever. Prednisone or other steroids can be given to help with the inflammation as well. Although there is not enough evidence showing their benefit, they are useful in patients with underlying chronic obstructive pulmonary disease (COPD) or asthma. Typically the steroid is used as short-term burst therapy. Sometimes a longer tapering dose of steroids might be warranted, especially in patients with underlying asthma or COPD.[13][14]

ACCP guidelines recommend against antibiotic use in simple acute bronchitis in otherwise healthy adults. A Cochrane review of nine randomized, controlled trials of antibiotic agents showed a minor reduction in the total duration of cough (0.6 days). The decrease in the number of days of illness was not significant per this review.[15] Hence antibiotic use should be avoided in simple cases considering the cost of antibiotics, the growing global problem of antibiotic resistance, and the possible side effects of antibiotic usage. Multiple other international medical societies recommend against antibiotic use in viral acute bronchitis. Despite these recommendations, a large proportion of patients with acute bronchitis are prescribed antibiotics. No data exist to justify the prospect of cough being less severe or less prolonged with antibiotic therapy. Antimicrobial therapy is recommended when a treatable pathogen is identified such as influenza or pertussis. In patients with influenza infection, oseltamivir or zanamivir should be promptly started. Macrolides are the treatment of choice for pertussis along with 5 days of isolation. It is interesting to note that whooping cough is only present in a minority of patients with pertussis. 

Procalcitonin might be useful in deciding on antibiotic use when the diagnosis of acute bronchitis is uncertain. A meta-analysis demonstrated procalcitonin-guided antibiotic therapy reduced antibiotic exposure and improved survival.[16]

Lifestyle modification like smoking cessation and the avoidance of allergens and pollutants play an important role in the avoidance of recurrence and complications. Flu vaccine and pneumonia vaccine are especially recommended in special groups including adults older than 65, children younger than two years (older than six months), pregnant women, and residents of nursing homes and long-term care facilities. People with asthma, COPD, and other immunocompromised adults are also at higher risk of developing complications. Recurrence is seen in up to a third of the cases of acute bronchitis.

In summary, the data for the use of beta-agonists, steroids, and mucolytic agents, especially in patients with no underlying COPD and asthma, is lacking. Treatment should be guided by the individual response to them and reported benefit, as well as, weighing risk and benefit in each case.

Differential Diagnosis

Other causes of acute cough should be considered especially when a cough persists for longer than 3 weeks. 

• Asthma: Acute asthma is misdiagnosed as acute bronchitis in approximately one-third of the patients who present with acute cough.
• Acute/chronic sinusitis
• Bronchiolitis
• COPD
• Gastroesophageal reflux disease (GERD)
• Viral pharyngitis
• Heart failure
• Pulmonary embolism

Prognosis

Acute bronchitis is self-limiting and resolves with symptomatic treatment in most instances. Secondary pneumonia is possible. Rare cases of acute respiratory distress syndrome and respiratory failure have been reported in the literature.[17][18]

Complications

• Secondary pneumonia
• Respiratory distress
• Days missed of school/work

Deterrence and Patient Education

Patients with acute bronchitis should be made aware of the importance of lifestyle modifications including smoking cessation and the avoidance of allergens and pollutants to lower their risk of recurrence and complications. Influenza and pneumonia immunizations are especially recommended in special groups including adults older than 65, children younger than two years (older than six months), pregnant women, and residents of nursing homes and long-term care facilities. Patients should also be provided education regarding the risks of prescribing antibiotics when they are not indicated including antibiotic resistance, cost, and potential side effects.

Pearls and Other Issues

Sometimes secondary pneumonia can develop. This is usually indicated by worsening symptoms, productive cough, and fever. In such cases, a chest x-ray is indicated. This is especially important in immunocompromised adults, the elderly population, infants and newborns, and smokers. Pulmonary emboli should always be in differentials in a patient with a cough and shortness of breath. Sometimes aggressive coughing can lead to spontaneous pneumothorax and or spontaneous pneumomediastinum. Hence any acute worsening of symptoms usually requires a chest x-ray.

Enhancing Healthcare Team Outcomes

Acute bronchitis is a very common disorder that frequently presents to emergency departments and primary care offices. It is a very common cause of absenteeism from work and school. The condition is best managed by an interprofessional team that includes a primary care provider, a nurse, a pharmacist, and a pulmonologist. The key is coordinating patient education. The nursing staff should be tasked to work with patients to stop smoking and avoid exposure to secondhand smoke. The nurses should encourage individuals to get influenza and pneumococcal vaccines to reduce morbidity. The nurses should monitor patients for compliance and report back to the clinical team leader patients that are non-compliant with smoking cessation. In addition, the nurse and pharmacist should encourage hand washing to limit the spread of micro-organisms.

For those patients whose cough persists, the nurses should monitor for the possibility of atypical pneumonia or pneumonia that requires antibiotic therapy. In these cases, the nurse should arrange a follow-up visit with the clinical team for re-assessment. If an antibiotic is deemed necessary, the pharmacist should evaluate for drug-drug interaction and allergy prior to filling the prescription. If there are any concerns, the pharmacist should make the clinical team aware of potential problems before the drug is dispensed.

The outcomes of patients with acute bronchitis are good; however, it is a common reason for absenteeism from work. In some patients with underlying COPD and other lung problems, acute bronchitis can have high morbidity. Patients whose symptoms persist for more than six weeks need to be re-evaluated to ensure that the diagnosis is correct. [Level 5][19][20]

Review Questions

• Access free multiple choice questions on this topic.
• Comment on this article.

References

1.

Adams PF, Hendershot GE, Marano MA., Centers for Disease Control and Prevention/National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10. 1999 Oct;(200):1-203. [PubMed: 15782448]

2.

Pulia M, Redwood R, May L. Antimicrobial Stewardship in the Emergency Department. Emerg Med Clin North Am. 2018 Nov;36(4):853-872. [PMC free article: PMC7094813] [PubMed: 30297009]

3.

Saust LT, Bjerrum L, Siersma V, Arpi M, Hansen MP. Quality assessment in general practice: diagnosis and antibiotic treatment of acute respiratory tract infections. Scand J Prim Health Care. 2018 Dec;36(4):372-379. [PMC free article: PMC6381521] [PubMed: 30296885]

4.

Tanner M, Karen Roddis J. Antibiotics for acute bronchitis. Nurs Stand. 2018 Feb 28;32(27):41-43. [PubMed: 29488727]

5.

Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1 Suppl):95S-103S. [PMC free article: PMC7094612] [PubMed: 16428698]

6.

Kronman MP, Zhou C, Mangione-Smith R. Bacterial prevalence and antimicrobial prescribing trends for acute respiratory tract infections. Pediatrics. 2014 Oct;134(4):e956-65. [PubMed: 25225144]

7.

Bai L, Su X, Zhao D, Zhang Y, Cheng Q, Zhang H, Wang S, Xie M, Su H. Exposure to traffic-related air pollution and acute bronchitis in children: season and age as modifiers. J Epidemiol Community Health. 2018 May;72(5):426-433. [PubMed: 29440305]

8.

Wenzel RP, Fowler AA. Clinical practice. Acute bronchitis. N Engl J Med. 2006 Nov 16;355(20):2125-30. [PubMed: 17108344]

9.

Altiner A, Wilm S, Däubener W, Bormann C, Pentzek M, Abholz HH, Scherer M. Sputum colour for diagnosis of a bacterial infection in patients with acute cough. Scand J Prim Health Care. 2009;27(2):70-3. [PMC free article: PMC3410464] [PubMed: 19242860]

10.

Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, Greenberg DP, Keitel W, Barenkamp S, Bernstein DI, Edelman R, Edwards K., APERT Study Group. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med. 2005 Oct 13;353(15):1555-63. [PubMed: 16221778]

11.

Smucny J, Becker L, Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001726. [PubMed: 17054140]

12.

Becker LA, Hom J, Villasis-Keever M, van der Wouden JC. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. Cochrane Database Syst Rev. 2015 Sep 03;2015(9):CD001726. [PMC free article: PMC7078572] [PubMed: 26333656]

13.

Smith DRM, Dolk FCK, Pouwels KB, Christie M, Robotham JV, Smieszek T. Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care. J Antimicrob Chemother. 2018 Feb 01;73(suppl_2):ii11-ii18. [PMC free article: PMC5890733] [PubMed: 29490061]

14.

Llor C, Bjerrum L. Antibiotic prescribing for acute bronchitis. Expert Rev Anti Infect Ther. 2016 Jul;14(7):633-42. [PubMed: 27219826]

15.

Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000245. [PubMed: 15494994]

16.

Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Annane D, Reinhart K, Falsey AR, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Oliveira CF, Maravić-Stojković V, Verduri A, Beghé B, Cao B, Shehabi Y, Jensen JS, Corti C, van Oers JAH, Beishuizen A, Girbes ARJ, de Jong E, Briel M, Mueller B. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018 Jan;18(1):95-107. [PubMed: 29037960]

17.

Ngu S, Pervaiz S, Avula A, Chalhoub M. Rhinovirus-induced Rapidly Progressing Acute Respiratory Distress Syndrome in an Immunocompetent Host. Cureus. 2019 Feb 01;11(2):e3997. [PMC free article: PMC6443533] [PubMed: 30989006]

18.

Soni P, Rai A, Aggarwal N, Kamholz S, Yoon T, Kupfer Y. Enterovirus-Human Rhinovirus: A Rare Cause of Acute Respiratory Distress Syndrome. J Investig Med High Impact Case Rep. 2017 Jul-Sep;5(3):2324709617728526. [PMC free article: PMC5588805] [PubMed: 28904980]

19.

Bettoncelli G, Blasi F, Brusasco V, Centanni S, Corrado A, De Benedetto F, De Michele F, Di Maria GU, Donner CF, Falcone F, Mereu C, Nardini S, Pasqua F, Polverino M, Rossi A, Sanguinetti CM. The clinical and integrated management of COPD. Sarcoidosis Vasc Diffuse Lung Dis. 2014 May 12;31 Suppl 1:3-21. [PubMed: 24820963]

20.

Palmer R, Anon JB, Gallagher P. Pediatric cough: what the otolaryngologist needs to know. Curr Opin Otolaryngol Head Neck Surg. 2011 Jun;19(3):204-9. [PubMed: 21499103]